Biomarker testing is crucial for personalized oncology care, aiding in risk stratification and treatment decisions, but faces ...

Biomarker testing is changing how colorectal cancer is treated, giving patients more personalized and effective care. By ...

The American Society for Clinical Pathology (ASCP), in collaboration with Pfizer and with participation from the American Society of Clinical Oncology (ASCO), announced a Request for Proposals (RFP) ...

Imagine this: someone you love has just heard the words “you have cancer.” They are meeting with their oncologist – perhaps even me, or one of my colleagues – and come to understand that there is ...

Oncology pharmacists bridge gaps in test ordering, result interpretation, and therapy access, ensuring timely and effective ...

Across all cancer types, less than 50% of patients underwent biomarker testing before first-line treatment. Many patients with advanced cancer do not receive guideline-recommended biomarker testing ...

If more extensively insured, the cutting-edge treatment could reduce health disparities for cancer patients and improve ...

Almost all of us have been touched by cancer at some point in our lives. If we haven’t had it, chances are we know a loved one or a friend who has. When someone dies from cancer, families go through ...

Precision Care Companion (PCC) enhances biomarker testing and precision therapy adoption in community oncology, uniting practices, labs, and biopharma for improved patient outcomes. PCC focuses on ...

New global initiative urges patients and clinicians to wait for biomarker testing results before starting treatment.

‘I Tried Midi Health for Biomarker Testing—Here’s What I Learned About My Health’ originally appeared on Parade. Considering that I’m a journalist, it’s not a surprise that I believe that knowledge is ...

Please provide your email address to receive an email when new articles are posted on . Most patients with nonsquamous NSCLC treated at academically-affiliated community clinics received ...